Age related macular degeneration is the leading cause of vision loss in adults over 50. Early detection through advanced imaging is the most powerful tool we have to slow its progression.
Macular degeneration affects the center of your retina, gradually destroying the sharp central vision needed for reading, driving, and recognizing faces. We use OCT and Optomap imaging to detect even subtle changes before vision loss occurs.
By the time most patients notice vision changes, significant damage may have already occurred. Regular monitoring can change that outcome.
Adults 50 and older
Age is the single greatest risk factor for AMD. Annual retinal imaging is recommended for all adults over 50, even without symptoms or family history.
Family history of AMD
Genetics play a significant role in AMD risk. If a parent or sibling has been diagnosed, your risk is substantially higher and earlier screening is essential.
Smokers & high risk patients
Smoking dramatically increases AMD risk. Patients with cardiovascular disease, obesity, or long-term sun exposure are also at elevated risk and should be monitored more closely.
AMD monitoring at Santé Eyecare is thorough but efficient. We document a baseline, track changes visit to visit, and communicate clearly so you always know where things stand.
High resolution OCT scans capture detailed cross sections of your retinal layers, allowing us to detect drusen, fluid, and other AMD related changes at the earliest stage.
We compare each visit's imaging to your baseline, allowing us to identify even subtle changes that indicate progression from early to advanced AMD.
We discuss evidence-based strategies to slow AMD progression, including AREDS2 supplements, UV protection, diet, and smoking cessation support.
Have a question not answered here? Feel free to call or text our team.
Dry AMD is the more common form and progresses slowly. It involves the gradual breakdown of light sensitive cells in the macula. Wet AMD is less common but more severe. It occurs when abnormal blood vessels grow under the retina and leak fluid, causing rapid vision loss. Early detection of dry AMD is critical to prevent conversion to wet.
There is currently no cure for AMD, but treatment options can slow progression and, in the case of wet AMD, help preserve vision. VEGF inhibitor injections are highly effective for wet AMD. For dry AMD, AREDS2 supplements, lifestyle changes, and regular monitoring are the primary management strategies.
Watch for blurry or distorted central vision, dark spots, difficulty reading small print, or straight lines appearing wavy. We recommend using an Amsler grid at home between visits. If you notice changes, contact us promptly. Early intervention for wet AMD can prevent significant vision loss.
Frequency depends on your stage and risk level. Early dry AMD may only require annual visits, while intermediate AMD typically warrants every 6 months. If you develop signs of wet AMD or rapid progression, you may need more frequent monitoring or urgent referral to a retinal specialist.
Yes. Clinical studies show that AREDS2 supplements (containing lutein, zeaxanthin, vitamin C, vitamin E, and zinc) can reduce the risk of AMD progression to advanced stages by approximately 25% in patients with intermediate or advanced AMD in one eye. We can discuss whether supplementation is appropriate for your situation.
Advanced imaging lets us catch changes long before vision is affected.